Sleep is a biological requirement which relaxes the mind and body, and also helps to maintain metabolic activities, and regulates immune function. Lack of sleep leads to many disorders, such as high blood pressure, diabetes, and other heart diseases. The sleep aids are medication or medical devices which are used to urge the sleep. This sleeping aids are used to treat the sleep disorder such as insomnia, narcolepsy (excess sleepiness), and others. These disorders are caused due to the depression, anxiety, and environmental factors.
MARKET DYNAMICS
The global sleep aids market is anticipated to grow in coming years owing to factors such as increase in stressful working, change in lifestyle, aging population, increase in geriatric population, and rise in consumption of alcohol, smoking, and others. The increase in advancement in technologies and awareness of sleep disorder are factors expected to provide new opportunities for market growth.
MARKET SCOPE
The "Global Sleep Aids Market Analysis to 2028" is a specialized and in-depth study with a special focus on the global medical device market trend analysis. The report aims to provide an overview of sleep aids market with detailed market segmentation by offering, sleep disorder, and geography. The global sleep aids market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading sleep aids market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global sleep aids market is segmented on the basis of offering, and sleep disorder. Based on offering, the market is segmented as mattresses & pillows, sleep laboratories services, medications, and sleep apnea devices. On the basis of sleep disorder, the global sleep aids market is segmented into insomnia, sleep apnea, restless legs syndrome, narcolepsy, sleep walking, and other. (image)
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global sleep aids market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The sleep aids market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting sleep aids market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the sleep aids market in these regions.
(image)
MARKET PLAYERSThe reports cover key developments in the sleep aids market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from sleep aids market are anticipated to lucrative growth opportunities in the future with the rising demand for sleep aids in the global market. Below mentioned is the list of few companies engaged in the sleep aids market.
The report also includes the profiles of key sleep aids market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
-Koninklijke Philips N.V.
-Merck Sharp & Dohme Corp Sanofi
-Sanofi
-DeVilbiss Healthcare LLC.
-Pfizer Inc.
-Teva Pharmaceutical Industries Ltd.
-Cadwell Industries, Inc.
-Compumedics Limited
-Serta, Inc.
-GlaxoSmithKline plc.
(image)